These leaflets explain the rare but serious diseases covered by the NHS newborn blood spot (NBS) screening programme.
The NHS newborn blood spot (NBS) screening programme helps identify several rare but serious diseases with a small blood sample, also called a heel prick test.
These diseases include the rare inherited metabolic diseases (IMD) introduced in January 2015.
Healthcare professionals and parents can refer to these leaflets to learn about the diseases and to discuss a baby’s test results.
Don’t include personal or financial information like your National Insurance number or credit card details.